LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.08
+0.07 (1.16%)
At close: Sep 17, 2025, 4:00 PM EDT
6.09
+0.01 (0.16%)
After-hours: Sep 17, 2025, 7:54 PM EDT
LifeMD Revenue
LifeMD had revenue of $62.22M in the quarter ending June 30, 2025, with 22.81% growth. This brings the company's revenue in the last twelve months to $245.56M, up 37.74% year-over-year. In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth.
Revenue (ttm)
$245.56M
Revenue Growth
+37.74%
P/S Ratio
1.06
Revenue / Employee
$799,882
Employees
307
Market Cap
288.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LFMD News
- 2 hours ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LifeMD, Inc. (LFMD) - GlobeNewsWire
- 12 hours ago - Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman - GlobeNewsWire
- 1 day ago - Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman - PRNewsWire
- 4 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - PRNewsWire
- 5 days ago - Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements – Hagens Berman - GlobeNewsWire
- 9 days ago - Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 13 days ago - Berger Montague PC Investigates Securities Claims Against LifeMD, Inc. (NASDAQ: LFMD) - PRNewsWire
- 20 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - GlobeNewsWire